US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.57

+0.12000.41%

Volume:2K

Turnover:65.98K

Market Cap:31.04M

PE:- -

High:29.68

Open:29.49

Low:29.41

Close:29.45

52wk High:33.59

52wk Low:23.00

Shares:1.05M

Float Shares:1.05M

Volume Ratio:0.78

T/O Rate:0.21%

Dividend:0.07

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million

Hims & Hers Health Q2 EPS USD -0.37

THOMSON REUTERS

Hims & Hers Health, Inc. Q3 REV View $793.1 Mln

THOMSON REUTERS

Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda

THOMSON REUTERS

Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year

THOMSON REUTERS

U.S. Earnings Preview: After Market Close Aug. 10

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings

Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test

Simply Wall St.

Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock

Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network

Simply Wall St.

Oscar Health Price Target Raised to $39.00/Share from $35.00 by Barclays

Polymarket Odds: Will RKLB, HIMS, QUBT Beat Earnings on Monday?

UBS Adjusts Oscar Health Price Target to $26 From $20, Maintains Neutral Rating

MT Newswires Live

Oscar Health price target raised to $27 from $19 at Baird

Oscar Health Stock And 2 Fast Growing US Companies Investors May Want To Watch

Simply Wall St.

Oscar Health Earnings Call Signals Profitable Scale-Up

Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’

Rocket Doctor AI Raises CAD $2.27 Million in Oversubscribed Debenture Financing to Fuel U.S. Expansion

Oscar Health price target raised to $39 from $35 at Barclays

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/HEAL/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HEAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","market":"US","secType":"STK","nameCN":"Global X HealthTech ETF","latestPrice":29.565,"timestamp":1788379200000,"preClose":29.445,"halted":0,"volume":2231,"delay":0,"changeRate":0.004075394803871659,"floatShares":1049843,"shares":1049843,"eps":0,"marketStatus":"Pre-Mkt","change":0.12,"latestTime":"09-03 07:05:22 EDT","open":29.49,"high":29.68,"low":29.41,"amount":65981.149007,"amplitude":0.00917,"askPrice":30.5,"askSize":7,"bidPrice":19,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":29.565,"sharesOutstanding":1329868,"nav":29.47,"aum":30941215.67,"dividendRate":0.002412,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.58,"preClose":29.565,"latestTime":"19:30 EDT","volume":13,"amount":384.345,"timestamp":1788391806427,"change":0.015,"changeRate":0.000507,"amplitude":0},"volumeRatio":0.775352719368597,"impliedVol":0.0888,"impliedVolPercentile":0.4064},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","floatShares":1049843,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.775352719368597,"shares":1049843,"dividePrice":0.0713,"high":29.68,"amplitude":0.00917,"preClose":29.445,"low":29.41,"week52Low":23,"pbRate":"--","week52High":33.59,"institutionHeld":0,"latestPrice":29.565,"committee":-0.75,"eps":0,"divideRate":0.002412,"volume":2231,"delay":0,"ttmEps":0,"open":29.49,"prevYearClose":29.215,"prevWeekClose":29.715,"prevMonthClose":29.6135,"prevQuarterClose":27.59,"fiveDayClose":29.705,"twentyDayClose":27.85,"sixtyDayClose":25.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HEAL\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HEAL","amount":0.071843,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"HEAL","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2025-06-27","symbol":"HEAL","amount":0.00815,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HEAL\",market:\"US\",,,undefined,":[{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00815,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.071843,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HEAL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HEAL\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658959895","title":"Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959895","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959895?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:06","pubTimestamp":1786392361,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 MillionAug 10  - Hims & Hers Health Q2 net income USD -86.3 million.outlook FY revenue USD 3,100-3,300 million vs. IBES estimate USD 2,928 millionoutlook FY adjusted EBITDA USD 275-325 million vs. IBES estimate USD 296.2 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIMY","HIMS","HEAL","HIMZ","HIYY","BK4196","THNR","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959814","title":"Hims & Hers Health Q2 EPS USD -0.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959814?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","HIMZ","BK4196","HIYY","HIMY","HEAL","HMYY","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959546","title":"Hims & Hers Health, Inc. Q3 REV View $793.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959546?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HEAL","HIMS","THNR","GLAM","BK4196","HIMZ","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956027","title":"Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956027?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMZ","GLAM","HIMS","HIYY","HEAL","THNR","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658051956","title":"Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658051956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658051956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","HIMZ","BK4196","HIYY","HIMY","HEAL","HMYY","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956339","title":"U.S. Earnings Preview: After Market Close Aug. 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956339","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956339?lang=en_us&edition=fundamental","pubTime":"2026-08-11 03:30","pubTimestamp":1786390200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the marke","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","ARCX","ERET","LU2308191902.HKD","BK4204","LU0689626769.HKD","REIT","BK4585","AVRE","LU2298064838.USD","IE00B66KJ199.SGD","BK4129","ACHR","GQRE","IYRI","ICF","BK4588","LU0187121727.USD","CRED","BK4213","URE","RSPR","BK4505","LU2244417387.USD","BK4203","LU0842063009.USD","BK4080","APEI","LU1861214812.USD","BBRE","NHI","VNQ","BK4603","BK4231","HPK","LU1939255532.USD","HIYY","REET","JRE","RITA","DFGR","LU0124676726.USD","LU2190626999.HKD","LU2360107325.USD","XLRE","BK4187","BK4196","HIMZ","GLAM","BK4516","BKD","HLIO","BK4139","BK4161","HIMY","FRI","BK4088","LU1861219969.SGD","BK4137","BK4166","VGSR","IYR","SCHH","DPRE","RNTY","LU2238339852.HKD","IQRA","IE00B19Z4B17.USD","IE0031619046.USD","BZH","UPWK","USRT","FREL","RWR","SPG","IE00B7SZL793.SGD","HIMS","BK4130","HMYY","ACM","LU1499592464.USD","DFAR","BBIO","HEAL","TRUR","OPFI","RWO","ACVA","BK4225","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939006","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658939006?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:50","pubTimestamp":1786366208,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Dianthus Therapeutic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","HEAL","HIMY","HMYY","BK4196","HIYY","BK4139","HIMZ","IBRN","THNR","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980780","title":"Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980780","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980780?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:58","pubTimestamp":1786359487,"startTime":"0","endTime":"0","summary":"HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61068991/hims-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIMS","GLAM","BK4196","THNR","HMYY","HEAL","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670176","title":"Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670176","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658670176?lang=en_us&edition=fundamental","pubTime":"2026-08-10 00:30","pubTimestamp":1786293017,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) is back in focus after CellCarta added the company to its CDx Commercialization Lab Network, linking Tempus Hub ordering to CellCarta testing and tightening access to oncology companion diagnostics for U.S. providers.\nSee our latest analysis for Tempus AI.\nTempus AI’s recent CellCarta partnership, PRISM2 publication and earnings update have arrived alongside a sharp 1-day share price return of 12.86% and a 7-day share price return of 18.65%. However, the year-to-date share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-after-cellcarta-deal-and-prism2-validation-fac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-after-cellcarta-deal-and-prism2-validation-fac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4613","TEMT","BK4121","LU1861558580.USD","TEM","HEAL","LU1861559042.SGD","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658676186","title":"Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2658676186","media":"TIPRANKS","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658676186?lang=en_us&edition=fundamental","pubTime":"2026-08-09 07:19","pubTimestamp":1786231179,"startTime":"0","endTime":"0","summary":"Telehealth platform Hims & Hers Health ($HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to close at $31.59 on Fr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-hers-q2-earnings-preview-options-traders-brace-for-a-14-5-move-in-hims-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-hers-q2-earnings-preview-options-traders-brace-for-a-14-5-move-in-hims-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIYY","GLAM","HMYY","HIMS","THNR","HIMZ","HEAL","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657845678","title":"Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2657845678","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657845678?lang=en_us&edition=fundamental","pubTime":"2026-08-08 20:31","pubTimestamp":1786192260,"startTime":"0","endTime":"0","summary":"On 6 August 2026, CellCarta Inc. said it would add Tempus AI to its CDx Commercialization Lab Network, with Tempus using its Tempus Hub to manage provider test ordering, sample routing to CellCarta, and result delivery for oncology-focused companion diagnostics in the U.S.\nThis collaboration links Tempus AI’s ordering and data platform with CellCarta’s development and regulatory capabilities, aiming to close the gap between CDx approval and real-world clinical access for cancer...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/why-tempus-ai-tem-is-up-186-after-joining-cellcartas-cdx-com","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/why-tempus-ai-tem-is-up-186-after-joining-cellcartas-cdx-com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TEMT","BK4613","LU1861559042.SGD","HEAL","LU1861558580.USD","TEM","BK4121","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657623116","title":"Oscar Health Price Target Raised to $39.00/Share from $35.00 by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2657623116","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657623116?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:56","pubTimestamp":1786128960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OSCR/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSCX","OSCR","HEAL","BK4162","OSCG","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657734628","title":"Polymarket Odds: Will RKLB, HIMS, QUBT Beat Earnings on Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657734628","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657734628?lang=en_us&edition=fundamental","pubTime":"2026-08-08 01:47","pubTimestamp":1786124865,"startTime":"0","endTime":"0","summary":"On Monday, August 10, Rocket Lab ($RKLB), Hims & Hers ($HIMS), and Quantum Computing ($QUBT) will release their earnings. All three companies will ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/polymarket-odds-will-rklb-hims-qubt-beat-earnings-on-monday?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/polymarket-odds-will-rklb-hims-qubt-beat-earnings-on-monday?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","HIMZ","QUBX","THNR","BK4170","BK4196","HIMS","BK4608","HIMY","HEAL","BK4585","BK4602","CQTM","DIPR","BK4615","RKLB","HIYY","BK4564","FSPC","QTUP","RKLX","BK4187","GLAM","RKLZ","QUBT","HMYY","BK4591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644514","title":"UBS Adjusts Oscar Health Price Target to $26 From $20, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657644514?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:16","pubTimestamp":1786112199,"startTime":"0","endTime":"0","summary":"Oscar Health (OSCR) has an average rating of hold and mean price target of $22.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OSCR","OSCG","HEAL","OSCX","BK4551","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643678","title":"Oscar Health price target raised to $27 from $19 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643678?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:01","pubTimestamp":1786104091,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Oscar Health (OSCR) to $27 from $19 and keeps a Neutral rating on the shares. The firm said there were alot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oscar-health-price-target-raised-to-27-from-19-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oscar-health-price-target-raised-to-27-from-19-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HEAL","BK4551","OSCG","OSCX","OSCR","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657342616","title":"Oscar Health Stock And 2 Fast Growing US Companies Investors May Want To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2657342616","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657342616?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:36","pubTimestamp":1786088195,"startTime":"0","endTime":"0","summary":"US 10 year yields have retreated as oil prices eased, which has taken some pressure off inflation worries and put renewed attention on companies with healthier growth prospects. In that context, a focused screener for expected earnings growth and solid finances is especially interesting. This article walks through three stocks from the Healthy high growth potential screener that stand out and explains why they may deserve a closer look now.\nThe three stocks highlighted below are only a small...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-stock-and-2-fast-growing-us-companies-investors","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-stock-and-2-fast-growing-us-companies-investors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BROS","BK4588","LU1861220207.SGD","BK4551","OSCX","OSCG","HEAL","OSCR","BK4209","LU2360107671.USD","BK4585","BK4227","CHYM","LU1861217088.USD","BPAY","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657662823","title":"Oscar Health Earnings Call Signals Profitable Scale-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2657662823","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657662823?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:14","pubTimestamp":1786061641,"startTime":"0","endTime":"0","summary":"Oscar Health, Inc. (($OSCR)) has held its Q2 earnings call. Read on for the main highlights of the call. Oscar Health, Inc. struck an upbeat tone o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oscar-health-earnings-call-signals-profitable-scale-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oscar-health-earnings-call-signals-profitable-scale-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4162","OSCR","BK4551","OSCG","OSCX","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651269","title":"Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657651269?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:05","pubTimestamp":1786039556,"startTime":"0","endTime":"0","summary":"14:00 EDT Niagen Bioscience (NAGE) CFO highlights telehealth as ‘high-expectation growth channel’ Published first on TheFly – the ultimate source f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-cfo-highlights-telehealth-as-high-expectation-growth-channel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-cfo-highlights-telehealth-as-high-expectation-growth-channel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HTEC","FDIF","NAGE","HEAL","BMED","EKG","LGHT","GDOC","BK4121","BK4183","ANEW","CFO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659210","title":"Rocket Doctor AI Raises CAD $2.27 Million in Oversubscribed Debenture Financing to Fuel U.S. Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659210?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:33","pubTimestamp":1786037598,"startTime":"0","endTime":"0","summary":"Rocket Doctor AI ( ($TSE:AIDR) ) has provided an announcement. Rocket Doctor AI Inc., a Vancouver-based digital health and AI technology firm, prov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rocket-doctor-ai-raises-cad-2-27-million-in-oversubscribed-debenture-financing-to-fuel-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rocket-doctor-ai-raises-cad-2-27-million-in-oversubscribed-debenture-financing-to-fuel-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANEW","AGIX","BK4585","BK4588","EKG","CHAT","BMED","QTOC","AIPO","DTEC","FDHT","HTEC","AIQ","VTHR","GDOC","MDTX","HEAL","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657516659","title":"Oscar Health price target raised to $39 from $35 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2657516659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657516659?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:20","pubTimestamp":1786036841,"startTime":"0","endTime":"0","summary":"Barclays analyst Andrew Mok raised the firm’s price target on Oscar Health (OSCR) to $39 from $35 and keeps an Overweight rating on the shares. Pub...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oscar-health-price-target-raised-to-39-from-35-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oscar-health-price-target-raised-to-39-from-35-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","OSCR","BK4162","OSCX","OSCG","HEAL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}